Latest Insider Transactions at Baudax Bio, Inc. (BXRX)
This section provides a real-time view of insider transactions for Baudax Bio, Inc. (BXRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Baudax Bio, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Baudax Bio, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2022
|
Geraldine Henwood President and CEO |
BUY
Open market or private purchase
|
Direct |
1,200
+33.09%
|
$2,400
$2.55 P/Share
|
|
Jun 15
2022
|
Wayne Weisman Director |
BUY
Grant, award, or other acquisition
|
Direct |
39,473
+47.92%
|
-
|
|
Jun 15
2022
|
Geraldine Henwood President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
39,473
+44.57%
|
-
|
|
Jun 15
2022
|
Jillian Dilmore Corporate Controller/Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
15,467
+49.57%
|
-
|
|
Jun 15
2022
|
Andrew T Drechsler Director |
BUY
Grant, award, or other acquisition
|
Direct |
39,473
+48.65%
|
-
|
|
Jun 15
2022
|
Winston J Churchill Director |
BUY
Grant, award, or other acquisition
|
Direct |
39,473
+45.74%
|
-
|
|
Jun 15
2022
|
Arnold M Baskies Director |
BUY
Grant, award, or other acquisition
|
Direct |
39,473
+48.48%
|
-
|
|
Jun 15
2022
|
William Ashton Director |
BUY
Grant, award, or other acquisition
|
Direct |
39,473
+48.13%
|
-
|
|
Dec 15
2021
|
Geraldine Henwood President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
18,636
-5.24%
|
$0
$0.31 P/Share
|
|
Dec 05
2021
|
Geraldine Henwood President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,155
-2.51%
|
$0
$0.35 P/Share
|
|
Sep 22
2021
|
Geraldine Henwood President and CEO |
BUY
Open market or private purchase
|
Direct |
8,200
+2.2%
|
$0
$0.59 P/Share
|
|
Aug 31
2021
|
Winston J Churchill Director |
BUY
Open market or private purchase
|
Direct |
100,000
+28.0%
|
$0
$0.63 P/Share
|
|
Aug 20
2021
|
Richard S Casten Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
50,000
+20.0%
|
$0
$0.51 P/Share
|
|
Jun 07
2021
|
Winston J Churchill Director |
BUY
Open market or private purchase
|
Direct |
25,000
+7.62%
|
$0
$0.78 P/Share
|
|
May 14
2021
|
Richard S Casten Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
25,000
+14.29%
|
$0
$0.79 P/Share
|
|
May 11
2021
|
Arnold M Baskies Director |
BUY
Open market or private purchase
|
Direct |
10,000
+10.37%
|
$0
$0.82 P/Share
|
|
May 07
2021
|
Geraldine Henwood President and CEO |
BUY
Open market or private purchase
|
Direct |
6,000
+1.66%
|
$0
$0.83 P/Share
|
|
Apr 07
2021
|
Alfred Altomari Director |
BUY
Grant, award, or other acquisition
|
Direct |
56,452
+32.4%
|
-
|
|
Apr 07
2021
|
William Ashton Director |
BUY
Grant, award, or other acquisition
|
Direct |
56,452
+34.5%
|
-
|
|
Apr 07
2021
|
Winston J Churchill Director |
BUY
Grant, award, or other acquisition
|
Direct |
56,452
+29.93%
|
-
|
|
Apr 07
2021
|
Andrew T Drechsler Director |
BUY
Grant, award, or other acquisition
|
Direct |
56,452
+42.48%
|
-
|
|
Apr 07
2021
|
Wayne Weisman Director |
BUY
Grant, award, or other acquisition
|
Direct |
56,452
+32.0%
|
-
|
|
Apr 07
2021
|
Arnold M Baskies Director |
BUY
Grant, award, or other acquisition
|
Direct |
56,452
+42.48%
|
-
|
|
Mar 15
2021
|
Richard S Casten Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
25,000
+16.67%
|
$25,000
$1.41 P/Share
|
|
Mar 08
2021
|
Richard S Casten Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+47.97%
|
-
|
|
Jan 20
2021
|
Geraldine Henwood President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
65,435
+15.74%
|
-
|
|
Jan 15
2021
|
Ryan David Lake Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
26,658
-27.8%
|
$26,658
$1.3 P/Share
|
|
Jan 15
2021
|
Ryan David Lake Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+11.72%
|
-
|
|
Dec 05
2020
|
Geraldine Henwood President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
83,015
-11.6%
|
$83,015
$1.14 P/Share
|
|
Dec 05
2020
|
Ryan David Lake Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
19,909
-11.49%
|
$19,909
$1.14 P/Share
|
|
Nov 23
2020
|
Alfred Altomari Director |
BUY
Open market or private purchase
|
Direct |
5,000
+7.54%
|
$5,000
$1.06 P/Share
|